Investments in and Advances to Joint Ventures - Schedule of Reconciliation of Consolidated Joint Venture Equity (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Schedule Of Equity Method Investments [Line Items]
Company's share of accumulated equity	$ 27,801	$ 35,782
Basis differentials	2,385	1,099
Deferred leasing and development fees, net of portion related to the Company's interest	0	(136)
Amounts payable to the Company	1,993	2,627
Investments in and Advances to Joint Ventures, net	$ 32,179	$ 39,372